ARCHIVES

October issue of Business & Regulatory Report (8-page issue).

This article is from The Cancer Letter archive.

Vol. 28 No. 40 | November 2, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Simplifies Reporting Of Adverse Events

June 18, 1993

Conversations With The Cancer Letter: Youle: ACS Stance on Tobacco Sales Is Clear

April 18, 2014

In Brief: Satcher Confirmed For U.S. Surgeon General; Bishop Selected As Chancellor Of UCSF

February 13, 1998

Zevalin Regimen Better Than Rituximab Alone For NHL

June 29, 2001

Public Forum On NRSA Tuition Policies

April 14, 1995

ACCC Committee Hears Alternative Ways To Do Clinical Trials In Community

May 8, 1981